George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialized oncology CRO division
George Clinical, the leading Asia-Pacific CRO, expands into the USA with an acquisition of a specialized oncology CRO.
Headquartered in Sydney, Australia, George Clinical has offices in China, India, Hong Kong, South Korea, Taiwan, Malaysia, New Zealand, United Kingdom, Czech Republic and now multiple offices in the USA.
Over the years, George Clinical has grown rapidly across the Asia-Pacific region and is continuing to develop its global operations. The combination of a strong commercial proficiency and clinical research and scientific excellence positions George Clinical as a high quality, global CRO with substantial clinical and scientific assets.
George Clinical’s operations now expand further in the USA, with 66 new people and leaders specializing in oncology trials coupled with the existing team create an full capabilities offering. We are here to support our USA customers with their clinical trial and scientific consultation needs and to lead oncology trials across our core operational facilities in the Asia-Pacific region.
Central Nervous System 57%
Medical Devices 38%
|Number of Personnel||66|
|Official Language||English 79.2%, Spanish 12.9%, other Indo-European 3.8%, Asian and Pacific island 3.3%, other 0.9%|
|Hospital Records Language||English|
|In-country services||Business Development
Medical and Safety management
|GDP – per capita (US $)||$55,800|
|Health Expenditures||17.1% of GDP|